CMR characterization of ablation lesions following pulmonary vein isolation.

CMR characterization of ablation lesions following pulmonary vein isolation. - CMR characterization of ablation lesions

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52010

Enrollment

Registered

2021-03-18

Start date

2022-09-01

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult patients (age >=18 years old) Paroxysmal or persistent atrial fibrillation meeting guideline criteria. Anticipated pulonary vain isololation using index guided radiofrequency ablation techniques. Availability of contrast-enhanced cardiac MRI within 3 months before anticipated pulmonary vein isolation.

Exclusion criteria

Exclusion criteria: History of catheter ablation History of cardiac surgery History of chest radiation therapy Known (or suspected) allergic reaction to gadolinium Estimated glomerular filtration rate (eGFR)

Design outcomes

Primary

Measure	Time frame
The relation between ablation lesion characteristics in the early phase after pulmonary vein isolation and (1) ablation scar at 3 months follow-up, and (2) atrial fibrillation-free survival at 1 year.	—

Secondary

Measure	Time frame
N.a.	—

Countries

Netherlands

Outcome results